Current Science

Open Access Open Access  Restricted Access Subscription Access

How to make Clinical Trials Registry-India world class


Affiliations
1 Institute of Bioinformatics and Applied Biotechnology, Biotech Park, Electronics City Phase 1, Bengaluru 560 100, India., India
 

All clinical trial registries probably have some lacunae concerning the number and quality of their records. This article deals with the Clinical Trials Registry-India (CTRI). It describes 10 categories of problems with the data and some proposed solutions. In their registration practices, some trialists do not follow the rules or may break the law. The need to comply with WHO requirements is emphasized, as well as the need for CTRI to go beyond what is currently required by WHO. With improvement in the organizational functioning of CTRI, it could be amongst the best registries in the world

Keywords

Clinical Trials.gov, Ctri, Data Integrity, Ethics, Registry, Who.
User
Notifications
Font Size

  • Dickersin, K. and Rennie, D., Registering clinical trials. JAMA, 2003, 290, 516–523.

  • Saberwal, G., The many uses of data in public clinical trial registries. Curr. Sci., 2021, 120, 1686–1691.

  • Krleža-Jerić, K., Clinical trial registration: the differing views of industry, the WHO, and the Ottawa Group. PLoS Med., 2005, 2, e378.

  • Venugopal, N. and Saberwal, G., A comparative analysis of important public clinical trial registries, and a proposal for an interim ideal one. PLoS ONE, 2021, 16, e0251191.

  • Zarin, D. A., Tse, T., Williams, R. J. and Rajakannan, T., Update on trial registration 11 years after the ICMJE policy was established. N. Engl. J. Med., 2017, 376, 383–391.

  • Zarin, D. A., Tse, T., Williams, R. J., Califf, R. M. and Ide, N. C., The ClinicalTrials.gov results database – update and key issues. N. Engl. J. Med., 2011, 364, 852–860.

  • Fleminger, J. and Goldacre, B., Prevalence of clinical trial status discrepancies: a cross-sectional study of 10,492 trials registered on both ClinicalTrials.gov and the European Union Clinical Trials Register. PLoS ONE, 2018, 13, e0193088.

  • Pillamarapu, M., Mohan, A. and Saberwal, G., An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry-India. Trials, 2019, 20, 535.

  • Nundy, S. and Gulhati, C. M., A new colonialism? – Conducting clinical trials in India. N. Engl. J. Med., 2005, 352, 1633–1636.

  • Pandey, A., Aggarwal, A., Maulik, M., Gupta, J. and Juneja, A., Challenges in administering a clinical trials registry: lessons from the Clinical Trials Registry-India. Pharmaceut. Med., 2013, 27, 83–93.

  • Chakraborty, I., Shreya, A., Mendiratta, J., Bhan, A. and Saberwal, G., An analysis of deficiencies in the ethics committee data of certain interventional trials registered with the Clinical Trials Registry India. PLoS Global Public Health, 2022, 2, e0000617.

  • http://ctri.nic.in/Clinicaltrials/alert.php (accessed on 2 March 2023).

  • Chakraborty, I. and Saberwal, G., CTRI has required prospective registration since 1 April 2018 – this has not always happened. Indian J. Med. Ethics., 2022, 7, 312–314.

  • Kumari, S., Mohan, A. and Saberwal, G., Hidden duplicates: 10s or 100s of Indian trials, registered with ClinicalTrials.gov, have not been registered in India, as required by law. PLoS ONE, 2020, 15, e0234925.

  • WHO, International standards for clinical trial registries: the registration of all interventional trials is a scientific, ethical and moral responsibility. World Health Organization, Geneva, Switzerland, 2018.

  • Tharyan, P., Prospective registration of clinical trials in India: strategies, achievements and challenges. J. Evid. Based Med., 2009, 2, 19–28.

  • Goldacre, B. and Gray, J., OpenTrials: towards a collaborative open database of all available information on all clinical trials. Trials, 2016, 17, 164.

  • Lv, J.-W. et al., Do published data in trials assessing cancer drugs reflect the real picture of efficacy and safety? J. Natl. Compr. Cancer Netw., 2017, 15, 1363–1371.

  • Talebi, R., Redberg, R. F. and Ross, J. S., Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA. Trials, 2020, 21, 675.

  • Zarin, D. A., Fain, K. M., Dobbins, H. D., Tse, T. and Williams, R. J., 10-Year update on study results submitted to ClinicalTrials.gov. N. Engl. J. Med., 2019, 381, 1966–1974.

  • Choudhury, M. C., Chakraborty, I. and Saberwal, G., Discrepancies between FDA documents and ClinicalTrials.gov for orphan drugrelated clinical trial data. PLoS Global Public Health, 2022, 2, e0000261.

  • Pradhan, R. and Singh, S., Comparison of data on serious adverse events and mortality in ClinicalTrials.gov, corresponding journal articles, and FDA medical reviews: cross-sectional analysis. Drug Saf., 2018, 41, 849–857.

  • Chan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C. and Altman, D. G., Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA, 2004, 291, 2457–2465.

  • Maulik, M. et al., Letter on: An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry-India. Trials, 2020, 21, 38.

  • Mudur, G. S., Indian Council of Medical Research public database not ‘permanent’. The Telegraph, online, 19 June 2022; https://www. telegraphindia.com/india/indian-council-of-medical-research-public-database-not-permanent/cid/1870722 (accessed on 2 March 2023).


Abstract Views: 137

PDF Views: 86




  • How to make Clinical Trials Registry-India world class

Abstract Views: 137  |  PDF Views: 86

Authors

Gayatri Saberwal
Institute of Bioinformatics and Applied Biotechnology, Biotech Park, Electronics City Phase 1, Bengaluru 560 100, India., India

Abstract


All clinical trial registries probably have some lacunae concerning the number and quality of their records. This article deals with the Clinical Trials Registry-India (CTRI). It describes 10 categories of problems with the data and some proposed solutions. In their registration practices, some trialists do not follow the rules or may break the law. The need to comply with WHO requirements is emphasized, as well as the need for CTRI to go beyond what is currently required by WHO. With improvement in the organizational functioning of CTRI, it could be amongst the best registries in the world

Keywords


Clinical Trials.gov, Ctri, Data Integrity, Ethics, Registry, Who.

References





DOI: https://doi.org/10.18520/cs%2Fv124%2Fi7%2F785-789